Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 20.76 Min. order: 1 piece ★★★★★ 4.8 (216 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 28.60 Min. order: 1 piece ★★★★★ 4.8 (247 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 21.62 Min. order: 1 piece ★★★★★ 4.3 (47 reviews) Sold : Login>>